January 14 webinar now on YouTube.

'Updates on NIH’s efforts to advance myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research. The webinar features a scientific presentation by Vikram Chib, PhD, and Agostina Casamento-Morales, PhD, from Johns Hopkins University and Kennedy Krieger Institute.'

 
January 14 webinar now on YouTube.

'Updates on NIH’s efforts to advance myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research. The webinar features a scientific presentation by Vikram Chib, PhD, and Agostina Casamento-Morales, PhD, from Johns Hopkins University and Kennedy Krieger Institute.'


Slides:
https://www.nih.gov/sites/default/files/research-training/initiatives/mecfs/20250325-long-covid.pdf

Transcript:
https://www.nih.gov/mecfs/nih-me/cfs-advocacy-call-january-14-2025
 
There seem to be a few new ME/CFS grants funded by NIH. I was looking at the "Similar Projects" section for the Ian Lipkin Columbia center.
https://reporter.nih.gov/search/YFuWk8CcR0CFVRcwMz0FfQ/project-details/10878252#similar-Projects

These two caught me eye:

1R15HL177762-01
Mechanophenotyping RBC subpopulations in ME/CFS
RAMASUBRAMANIAN, ANAND K,
SAN JOSE STATE UNIVERSITY
https://reporter.nih.gov/search/YFuWk8CcR0CFVRcwMz0FfQ/project-details/11043930

1R21AI187895-01
MSC exosomes as probes for ME/CSF immune cell dysfunction
BELJANSKI, VLADIMIR
NOVA SOUTHEASTERN UNIVERSITY
https://reporter.nih.gov/search/YFuWk8CcR0CFVRcwMz0FfQ/project-details/11033351

@ME/CFS Skeptic anything else look new to you since your last blog on the topic of NIH funding?
 
9/8/25, Neurology Journal:'Advancements in Neurology: A Conversation with Dr. Walter Koroshetz - Part 1'

'In part one of this two-part series, Dr. Stacey Clardy talks with Dr. Walter Koroshetz about recent advancements in neurology, emerging genomic therapies, the evolving understanding of long COVID, and current NINDS priorities.'

WK: "So there's a lot of interest in understanding why you get Long COVID...but I think now the shift has to be there are people who three years later are still not better. The take-home point is that those people who are not better three years later they have a condition which really fits what's called myalgic encephalomyelitis, chronic fatigue syndrome, ME/CFS."

"...everyone suspected was a post-infectious chronic condition, but no one knew what the infection was and no one could prove it. In the COVID space, it's pretty clear it was related to COVID. And so that's really the mystery. What happens to people who have an infection? And it may not be something that puts you in the hospital, but it causes this chronic fatigue, pain, trouble sleeping, trouble with memory, and this very weird thing called post-exertional malaise, which is defined as just in layman's term, you may not be feeling good one day and next day you might feel a little better and you go to the store, go out, walk a mile to the store and come back and then you're basically wiped out for 3 days. something happens during the exercise that just makes everything worse for a period of time which could be 3 days some people might be 3 weeks and that's the really peculiar signature of ME/CFS and it's also turns out to be the single symptom in Long COVID that predisposes people to a chronic condition..so we're really into that mystery of what is this post-infectious condition...we have to really get in and figure out.."

"And then of course this now with Long COVID and the RECOVER program where we've grown 15,000 people into this amazing cohort study. We have the samples, we have the patients to try and get it get to the bottom of it. I always say that this is really the last great medical mystery of all the conditions that affect people - certainly large numbers of people where there's very little to no understanding - this is it.

And so it's a real challenge to understand it. RECOVER is our best chance at getting there. But I must say after 3 years, there's lots of culprits but no one knows who's really guilty yet in terms of the cause. The cohort is being followed up. There are samples, thousands of samples. There are studies that are still going on, the patients who have the symptoms. Depending on their symptoms, the studies are customized. And we have adults, we have children, and we have pregnant women cohorts. There's autopsy studies to try and see if people who die for whatever reason who have Long COVID whether we can see something under the microscope that it's just not going to be able to get at if you just start looking at blood samples that's ongoing.

And then there are a number of large number of groups around the country have been funded to try and understand the pathophysiology of Long COVID, there are clinical trials that are ongoing. Some of them are concluding soon and there's a new set that's going to be launched actually September 9th there's a meeting here in Bethesda of people coming in to pitch ideas on trial the next trials for Long COVID that's called RECOVER-TLC, that's the next phase of trial. So yeah, the work is ongoing we've been working and people may not know this, but Dr. Francis Collins asked NINDS probably 10 years ago to really come up and take hold of ME/CFS research along with the NIAID Institute. So we've been working with them on ME/CFS for years before COVID happened, and we're really good partners with them now along with the Heart, Lung and Blood institute on RECOVER.

In science and medicine, we always look for every opportunity to turn a tragedy into something better for the future. And this is the perfect example. I when I'm talking to these patients, I often say, look, in neurology clinics, we knew about this long before COVID because we've always seen patients who whether identified or unidentified have a virus. And we've seen this with a multitude of viruses. And then what COVID brought us was a high number of individuals, unfortunately. but a high number where we knew the culprit, right? So, they could be studied in a systematic way.

There's still progress. If you talk to people who have this condition, they had a really hard time finding doctors. A lot of doctors just didn't believe the patient. I'm not sure how you cannot believe a patient, but you know, they just felt frustrated. They didn't know what it was and they just assumed it was some psychological problem the patient was having. And that's very frustrating to people who are debilitated like that. The one silver lining of the Long COVID is that as you said, we had this pandemic and now there's hundreds of thousands of people with Long COVID. Pretty hard to brush that under the rug anymore. That's for sure. So hopefully more physicians will really seriously take the pains taking care of these folks now."
 
This NIH webinar announcement about "multi-system disorders" does not mention ME/CFS, but the list of speakers includes several familiar names (see link to agenda below).

From Mechanisms to Medicine: Rethinking the Discovery-to-Care Continuum in Multi-System Disorders
North Bethesda, MD
Wednesday, September 23 - Thursday, September 24

NIH website said:
This workshop brings together leading researchers, clinicians, and people with lived experience (PWLEs) to advance our collective understanding of complex multi-system disorders. Discussions will span a range of interconnected themes, including chronic overlapping pain conditions, infection-associated conditions, neuroimmune dysfunction, sex differences in disease presentation, genetic contributions, and autonomic nervous system dysfunction. Attendees will examine conditions that exemplify the complexity and convergence of these disorders, fostering dialogue that bridges scientific insight and patient experience.

We look forward to seeing you there!

Agenda here:


Registration is open from Thursday, July 9, 2026 to Wednesday, September 9, 2026

Registration link

EDIT: I forgot to mention that I got this from the News section of the MECFSnet website.
 
Last edited:
This NIH webinar announcement about "multi-system disorders" does not mention ME/CFS, but the list of speakers includes several familiar names (see link to agenda below).

"Complex multi-system disorder" now seems to eerily reminiscent of functional neurological disorder - an ambiguous and misleading catch-all name that obscures any real knowledge.

The crowd is motley but an intelligent delegate might find some things of interest in some talks. I don't see many non-US people there. Maybe it is now a rule that NIH cannot invite non-US scientists?

The pain genetics might be interesting.
 
An email I received from MECFSnet, which hosts the mapMECFS data portal, among other activities, and which is funded by NIH. I stole @Chandelier's nice way of formatting quoted text.


ME/CFS Exchange Webinar Series Launches October 8: Post-Acute Infection Symptoms​
​
We are launching the ME/CFS Exchange Webinar Series, hosted by the National Institute of Neurological Disorders and Stroke (NINDS) in partnership with the ME/CFS Research Network (MECFSnet). This quarterly webinar series will bring together researchers and experts from a variety of disciplines to share insights, foster collaboration, and help advance ME/CFS discovery.​
​
The first webinar will be held via Zoom on October 8 from 1:00 to 3:00 p.m. ET. It will focus on post-acute infection symptoms, including what causes them and why they persist. Speakers will discuss this topic in the context of diseases such as ME/CFS and basic research using model systems.​
​
​
​
​
Speakers:​
​
Relevant Publications:​
​

 
An email I received from MECFSnet, which hosts the mapMECFS data portal, among other activities, and which is funded by NIH. I stole @Chandelier's nice way of formatting quoted text.


ME/CFS Exchange Webinar Series Launches October 8: Post-Acute Infection Symptoms​
​
We are launching the ME/CFS Exchange Webinar Series, hosted by the National Institute of Neurological Disorders and Stroke (NINDS) in partnership with the ME/CFS Research Network (MECFSnet). This quarterly webinar series will bring together researchers and experts from a variety of disciplines to share insights, foster collaboration, and help advance ME/CFS discovery.​
​
The first webinar will be held via Zoom on October 8 from 1:00 to 3:00 p.m. ET. It will focus on post-acute infection symptoms, including what causes them and why they persist. Speakers will discuss this topic in the context of diseases such as ME/CFS and basic research using model systems.​
​
​
​
​
Speakers:​
​
Relevant Publications:​
​

Starts in just over two hours.
 
I listened to this. I'd be interested to hear what others thought.

I felt that Komaroff trotted out all the usual biobabble stuff.

Of course sickness behaviour has to be thought about carefully and some aspects of that may well be contributing to ME/CFS. But if the sickness behaviour experts keep getting told things such as ME/CFS involves low cortisol and poorly defined "inflammation", I'm not sure that we will get to the right answers.

I've just had a flu, with a fever and sweats and the full on sickness response. My body seems to be able to mount that response and then close it down. So, I don't think a simple idea of a 'stuck in 'on'' sickness response works. If a sickness response/sickness behaviour is part of the story, then there is going to be some nuance to it.
 
I thought much of it was a step in the right direction. I may be biased though because my question about DecodeME got a nice mention at the end :)

I've been reading a bit about the kinds of illness neurological circuits mentioned and what was said jives with my impression -- many more things are hardwired than we might imagine, and research has been advancing very quickly in the last few years with optogenetics. The more I read on it the more I go from "how could these systems be going wrong?" to "how are these systems not constantly going terribly wrong?"

It seemed like Komaroff was using 'neuroinflammation' to include the situation where the brain is perfectly fine and just running its normal sickness response circuitry (e.g. prostaglandins activating the fever response and things like that), which was a bit funny. The way things are going, it wouldn't surprise me if the field kind of walks backwards into doing circuit neuroscience all while calling it neuroinflammation.

It did make me wish again that we had a nice write up of the deal with cortisol (and maybe a mention of prolactin) to send out to folks in situations like this. I might try to reach out to Saper (if my brain will cooperate long enough) as he seems to be doing neuroscience around the hypothalamus, orexin, and other illness regulatory things as well.
 
Last edited:
Back
Top Bottom